LBA37 IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Vogel, A
  • Saborowski, A
  • Hinrichs, J
  • Ettrich, TJ
  • Ehmer, U
  • Martens, UM
  • Mekolli, A
  • De Toni, E
  • Berg, Tobias
  • Geißler, M
  • Maenz, M
  • Kirstein, M
  • Waldschmidt, D

publication date

  • September 2021